Market Insights Health OTC Pharmaceuticals

Vitamins & Minerals - France

France

In France, the Vitamins & Minerals market market generates a revenue of €161.50m in 2024.
It is projected to experience an annual growth rate of 4.58% (CAGR 2024-2029).
When compared globally, in China leads the market with a revenue of €4,941.00m in 2024.
On a per person basis, the revenue generated amounts to €2.49 in 2024.
France is experiencing a growing demand for natural and organic vitamins and minerals in the OTC Pharmaceuticals market.

Key regions: Canada, United Kingdom, India, Europe, Brazil

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Vitamins & Minerals market in France has experienced significant growth in recent years, driven by changing consumer preferences and increasing awareness of the importance of a healthy lifestyle. Customer preferences in the Vitamins & Minerals market in France have shifted towards natural and organic products, as consumers are becoming more conscious about the ingredients they consume. This trend is in line with the global market, where consumers are increasingly seeking products that are free from artificial additives and preservatives. Additionally, there is a growing demand for personalized nutrition, with consumers looking for products that cater to their specific dietary needs and goals. This has led to the rise of customized vitamin and mineral supplements, as well as the use of functional foods and beverages fortified with vitamins and minerals.One of the key trends in the Vitamins & Minerals market in France is the increasing popularity of plant-based products. This is driven by the growing number of consumers adopting vegetarian and vegan diets, as well as those seeking alternatives to animal-based products. Plant-based vitamins and minerals are seen as more sustainable and environmentally friendly, which resonates with the values of many French consumers. This trend is also influenced by the rise of flexitarianism, where individuals are reducing their meat consumption but not completely eliminating it from their diets.Another trend in the market is the focus on immune health. The COVID-19 pandemic has heightened awareness of the importance of a strong immune system, leading to increased demand for vitamins and minerals that support immune function. This trend is expected to continue in the coming years, as consumers prioritize their health and well-being.Local special circumstances in France also play a role in shaping the Vitamins & Minerals market. France has a strong tradition of gastronomy and a culture that values food and nutrition. This has led to a high level of consumer awareness and education about the importance of a balanced diet and the role of vitamins and minerals in overall health. Additionally, the French government has implemented regulations and initiatives to promote healthy eating habits, including the labeling of nutritional information on food products and the promotion of healthy school meals.Underlying macroeconomic factors, such as the growing middle class and increasing disposable income, have also contributed to the growth of the Vitamins & Minerals market in France. As consumers have more purchasing power, they are willing to invest in products that support their health and well-being. Furthermore, the aging population in France has created a demand for products that address age-related health concerns, such as bone health and cognitive function.In conclusion, the Vitamins & Minerals market in France is experiencing growth due to changing customer preferences, including a shift towards natural and organic products, personalized nutrition, and plant-based alternatives. The focus on immune health and the influence of local special circumstances, such as a strong food culture and government initiatives, are also driving factors. Underlying macroeconomic factors, such as the growing middle class and aging population, further contribute to the market's development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.